Chris Moronko

“John, I was hoping maybe you could talk a little bit about any efforts to kind of connect ancillary to pass sales on a pre-sale basis. basis i i know you've um you know the cruise lines are famous for this and you you recently brought in um you know some some new leadership there and marketing some i was hoping you…”

“And so, Brian, maybe we could spend a minute talking about kind of the broader supplement space and, you know, there's been some headlines around peptides potentially getting more broadly approved by the FDA and other things.”

“I was hoping we could spend a minute talking about kind of the Silicon Valley market you talked about with growth in AI. I think you guys have probably four or five hotels in that area proper.”

“I guess to start off, Brian or Daniel, I was hoping maybe you could at least bucket for us the recall impact, whether you want to talk about kind of Q3 or maybe full year 25 basis, just between things like RPD, volume, DOE, fleet costs, because I think not everyone appreciates the fact that those are all intertwined…”